VJOncology is committed to improving our service to you

ESMO 2019 | Predicting resistance to targeted therapies in melanoma

VJOncology is committed to improving our service to you

Christian Blank

Christian Blank, MD, PhD, Netherlands Cancer Institute, Amsterdam, The Netherlands, outlines how we might be able to predict resistance to targeted therapies in melanoma patients. This interview took place at the European Society for Medical Oncology (ESMO) 2019 congress in Barcelona, Spain.

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter